Bacteria of the genus Legionella are important causes of pneumonia [1] . In New Zealand, legionella pneumonia is relatively common; the rate for community-acquired cases is 11% [2] , and the rate for nosocomial cases is 13% [2a] . Immunosuppression, chronic lung disease, cigarette smoking, advanced age, and general anaesthesia are risk factors for the disease [3] , although in a large proportion of cases, there are no obvious predisposing factors. The overall mortality associated with legionella pneumonia is '"" 19% [4] but can be as high as 80% among immunocompromised patients [5] . Early initiation of appropriate therapy improves survival [5] .
Legionella pneumonia can be difficult to diagnose because the signs and symptoms are nonspecific and do not distinguish legionella infection from other common causes of pneumonia [3] . Existing laboratory tests lack sensitivity in detecting all species of Legion ella or provide only a retrospective diagnosis. Culture of sputum remains the diagnostic "gold standard" but requires the use of selective media, and growth is usually evident only after several days [6] . Direct fluorescence assay (DFA) of respiratory secretions can be performed rapidly; how-ever, this technique has a low sensitivity, and cross-reactions with other bacteria may produce false-positive results [6] . Urinary antigen testing with use of the currently available commercial kits has a high sensitivity but is available only for Legionella pneumophila serogroup 1 [7] . In many parts of the world, L. pneumophila serogroup 1 is the organism most commonly implicated in legionellosis; however, in some areas such as New Zealand, only a minority of proven infections are caused by this organism [8] . Determination of antibody titers can provide only a retrospective diagnosis, as seroconversion usually occurs 2-3 weeks after the onset of infection [9] .
PCR holds promise as a rapid diagnostic test for legionellosis. Because this technique can specifically detect small amounts of Legionella DNA, it has been applied to the identification of Legionella in environmental water [10, 11] , bronchoalveolar lavage fluid samples [12] [13] [14] [15] [16] , and intratracheal aspirates [17] . It has been used to detect Legionella DNA in urine samples from experimentally infected guinea pigs and from patients with legionella pneumonia, and, in some cases, the test results remained positive for> 3 weeks after the onset of infection [18] . L. pneumophila DNA has also been detected by means of PCR in both acute and convalescent sera from five patients with Legionella pneumonia [19] .
This technique thus has the potential to provide a rapid diagnosis of legionellosis with use of readily obtainable specimens. We report the use of PCR to detect Legionella DNA in both serum and urine samples from patients with pneumonia due to a wide range of Legionella species and serogroups.
Methods
Subjects and samples. Stored serum and urine samples from 28 patients with legionella pneumonia were tested for the em 1996; 23 (September) presence of Legionella DNA by means of PCR. All patients had been enrolled in one of two prospective pneumonia studies which were conducted at our institution: a study of communityacquired pneumonia, which was conducted from 1992 to 1993 [2] , and a study of nosocomial pneumonia, which was conducted from 1994 to 1995 [2a] . Entry into each study was based on appropriate clinical features and typical radiographic findings. As part of a comprehensive workup, urine and serum samples were collected from all patients and stored at -20°C. Only the samples from patients classified as having "definite" legionella pneumonia (see below) who had both serum and urine samples available were analyzed.
Urine and serum samples from 24 patients with pneumonia due to organisms other than Legionella were tested in a similar manner to serve as controls. All 24 of these patients had also been enrolled in either ofthe two pneumonia studies and lacked serological evidence or other evidence of recent legionella infection. Random urine and serum samples from four healthy volunteers were also included as controls. The diagnosis of infection due to non-Legionella organisms was based on the isolation of organisms from blood cultures and/or good-quality respiratory secretions and/or on the detection of specific antibodies in paired sera.
Isolation of bacterial DNA from urine and serum samples.
Total genomic DNA was isolated from urine and serum samples by a TRIzol (Gibco BRL, Life Technologies Inc., Gaithersburg, MD) DNA extraction method used according to the manufacturer's instructions. In brief, 300 J.LL of urine or 100 J.LL of serum was added to the lysis solution. Samples were vortexed and centrifuged, and the DNA was precipitated with the addition of 100% ethanol. After centrifugation, the DNA was washed twice with O.lM sodium citrate/10% ethanol. A final 75% ethanol wash was followed by redissolving the DNA in 400 J.lL of 8 mM NaOH. The DNA concentration was determined by measuring the optical density at 260/280-nm wavelengths in a Philips PU 8700 series UV visible scanning spectrophotometer (Philips, Cambridge, UK); 1 U was considered equivalent to 50 J.lg double-stranded DNA per mL.
PCR amplification of Legionella DNA. For detection of Legionella, two 20-mer primers, L5SL9 (5'-ACTATAGCG-ATTTGGAACCA-3') and L5SR93 (5'-GCGATGACCTAC-TTTCGCAT-3'), were used to amplify a 104-bp segment of the coding region of the 5S rRNA gene. These primers have been previously reported to detect all species of Legionella [21, 22] . Oligonucleotide primers were synthesized by the DNA synthesis facility, Molecular Pathology Unit, Canterbury Health Laboratories, Christchurch, New Zealand, with use of an abi model 391 oligonucleotide synthesizer (Perkin Elmer, Foster City, CA).
PCR amplification was performed in a volume of 50 J.lL containing 50 mMKC1, 10 mMTris (pH 9.0 at 25°C), 1.5 mM MgCh, 100 J.lM of each deoxynucleotide triphosphate, 0.2 J.lM of each primer, and 1.25 U of Taq polymerase. One microgram of DNA was used per reaction. For amplification of a single target DNA sequence, template DNA was initially denatured at 94°C for 2 minutes, followed by a total of 35 cycles at 94°C, 55°C, and 72°C each for 1 minute. This procedure was carried out by using a GeneAmp 2400 thermal cycler (Perkin Elmer). The resulting 104-bp PCR segment was visualized with use of 2% agarose gel electrophoresis, 0.1 J.lg/mL ethidium bromide, and ultraviolet fluorescence.
Confirmation of the specificity of the amplified PCR product. Restriction enzyme analysis was used to confirm the specificity of the amplified PCR product. Ten-microliter aliquots of the PCR product were digested with 5 U of the restriction endonuclease TaqI (Gibco BRL, Life Technologies Inc.) according to the manufacturer's instructions. The resulting DNA fragments were electrophoresed on a 12% nondenaturated polyacrylamide gel, stained with 1 J.lg/mL of ethidium bromide, and viewed under ultraviolet light. Species of Legionella that commonly cause human legionellosis (including all the species identified in this study) contain a single TaqI restriction site. Other bacteria that share a similar 5S rRNA sequence homology with Legionella, including Pseudomonas aeruginosa and Pseudomonas fluorescens, do not contain a TaqI restriction site.
Control procedures. Total genomic DNA from L. pneumophila, L. longbeachae, and L. micdadei served as positive controls. These organisms were cultured on BCYE-a agar and suspended in distilled water (one colony per 2 mL), and DNA was prepared by means of the TRIzol method. Total genomic DNA was added to urine and serum samples that were known to be negative, and these samples were processed in parallel with the test samples. False-positive PCR results were avoided by strict adherence to anticontamination measures [23] and by inclusion of a known negative serum or urine control and a reagent blank. 
Detection limit ofpeR. To assess the lower limit at which the assay detected DNA, urine samples from healthy volunteers were added to serial dilutions (0-1: 1,000) of L. pneumophila serogroup 4 DNA. Table 1 summarizes the data, including the results of investigations and use of antibiotics at the time samples were collected, for all patients with legionella pneumonia and for controls. All PCR results were confirmed by repeated testing. Legionella DNA was detected in the 1:1,000 dilution containing .....,0.4 jLg/mL of total DNA.
Results
Legionella DNA was detected in urine and/or serum samples from 18 (64%) of 28 patients with legionella pneumonia, but Legionella DNA was not detected in samples from the control group. The sensitivity of the test was similar for both urine and serum samples. The sensitivity of PCR assay of urine and/ or serum increased to 73% when only those samples collected within 4 days of the onset of symptoms were included.
Discussion
The present report is the first to demonstrate that Legionella DNA is detectable in both urine and serum samples from patients with legionella pneumonia due to a wide variety of Legionella species and serogroups. Furthermore, DNA was detectable early in the illness (from the day of first symptoms in some cases) and for up to 3 weeks in serum and 5 weeks in urine, regardless of whether antibiotic treatment had been administered.
The accurate diagnosis of legionella pneumonia has important treatment and public health implications. Many firstline antibiotics used to treat bacterial pneumonia are ineffective against Legionella species. The early detection of these organisms may lead to earlier initiation of appropriate therapy and improvement in clinical outcome [5] and may expedite the investigation of potential sources of infection.
Our findings are in keeping with those of previous investigators. Maiwald et al. [18] detected Legionella DNA in urine samples from 15 guinea pigs that were intraperitoneally infected with either L. micdadei or L. pneumophila serogroups 1, 3, or 6. Furthermore, the DNA of these organisms could be detected from 1 day to > 30 days after infection. These investigators also detected Legionella DNA in the urine of 11 patients with pneumonia; nine ofthese patients' infections were confirmed by other methods including culture, DFA testing, detection of antibodies, or detection of antigens in urine. Lindsay et al. [19] detected Legionella DNA in both acute and convalescent sera from five patients with proven cases of legionella pneumonia who were treated with erythromycin before sera samples were collected [19] . This study included one convalescent serum sample that was positive for Legionella DNA 37 days after the onset of the patient's symptoms.
The fact that Legionella DNA is present in urine and serum samples from infected patients is not surprising. The isolation of Legionella species from blood cultures [24] demonstrates that intact organisms enter the circulation during acute infection, whereas the presence of antigenuria during early infection [7] suggests that antigenemia is also present and that it is likely that other breakdown products (such as nucleic acids) are also present in serum and urine.
Although the detection of Legionella DNA in the urine of our patients with legionella pneumonia was highly specific, we found that it was less sensitive than reported by Maiwald et al. [18] despite the fact that we used similar primers. The PCR primer system that we used, which targeted the 5S rRNA gene with 35 cycles of amplification, detected small amounts of Legionella DNA, and the production of primer/dimers in each PCR reaction provided evidence of noninhibitory reactions. Collection of samples within 4 days of the onset of symptoms increased the sensitivity of the test even though the number of patients included in our study was small. Because excretion of DNA in urine can be intermittent [18] , the testing of serial samples collected on consecutive days may also increase the sensitivity of DNA detection. Prolonged storage, incorrect storage, temperature, and repeated freeze-thaw cycles can reduce the detection of nucleic acid by PCR [25, 26] . Some of the samples from patients with community-acquired pneumonia were stored for up to 3 years before testing, and this may have led to the reduced detection of Legionella DNA in these samples vs. more-recent samples.
Other investigators have repeatedly amplified DNA sequences in negative controls when they used the same PCR primer system for detecting Legionella DNA in environmental water samples [27] . This amplified product was thought to derive from bacterial DNA contaminating Taq DNA polymerase and had close homology to the 5S rRNA of P.fluorescens, P. aeruginosa, Alcaligenes faecalis, and Azotobacter vinelandii. To confirm that our amplified products were not derived from these organisms, we digested all products with the restriction endonuclease TaqI. This enzyme cuts the Legionella 5S rRNA gene into two fragments (33 bp and 71 bp) but does not cut the amplified sequences of other bacteria. The fact that both the PCR-negative controls and all samples from control patients were uniformly negative also makes contamination during specimen collection, extraction, and amplification unlikely.
The majority of Legionella infections in this study were due to organisms other than L. pneumophila serogroup 1, and all of these organisms were identified by detection of antibodies. The sensitivity and specificity of seroconversion for the diagnosis of these species and serogroups, unlike L. pneumophila serogroup 1, have not been rigorously confirmed [9] . Our preliminary data, which showed that PCR was positive for all Legionella species and for none of the control samples from patients who did not seroconvert after an episode of pneumonia, suggest that serology results may truly reflect the presence of legionella infection for organisms other than L. pneumophila serogroup 1. em 1996;23 (September) * Groups: I = patients with legionella pneumonia diagnosed based on at least a fourfold rise in antibody titers, with or without a positive sputum culture and f)FA positivity; 2 "" patients with pneumonia due to organisms other than Legionella and with serology not suggestive of legionellosis; 3 = healthy controls.
t Presence of at least a fourfold rise in titers of antibody in paired sera.
The advantages of PCR over conventional methods for the detection of Legionella DNA in urine and serum are evident. Urine and serum samples are readily obtainable and can be processed within a single working day, thereby providing a rapid result for the clinician. In our series, a positive sputum culture or DFA test led to a relatively early diagnosis or to clinical suspicion of legionellosis in only 12 (43%) of the 28 patients who had legionella pneumonia. PCR, if used at the time of specimen collection, would have detected an additional 11 cases; thus, only five patients would have had a solely retrospective diagnosis (i.e., a diagnosis based on a fourfold or greater rise in antibody titers). A test for L. pneumophila serogroup I antigen in urine was not available and would have contributed little to diagnostic accuracy given the minority of patients with infections due to this organism.
With use of PCR, the diagnosis of infection due to multiple etiologies can be made with more confidence. Concomitant infection with other pathogens occurs in an estimated 5% -1 0% of cases of legionella pneumonia, and this rate may be even higher among patients with nosocomial disease [3] . Therapy with macrolides may be discontinued prematurely or may not be initiated at all if an alternative diagnosis seems likely, especially in view of the lack of specificity associated with DFA testing and with a single high titer of antibodies to Legionella.
Our findings suggest that detection of Legionella DNA in urine and serum by PCR will be a valuable tool for assisting clinicians in the rapid diagnosis of legionella pneumonia. Further prospective studies are required in which multiple serum and urine samples from patients with legionella pneumonia are tested to determine the exact sensitivity and specificity of PCR and to determine patterns of DNA excretion over time in serum and urine.
